TL;DR: Macromoltek is a Y Combinator Winter 2018 startup Computational antibody design, currently active with a team of 14.
Computational antibody design
Last verified:
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Built by LemStudio
Yes. Macromoltek was funded by Y Combinator in the Winter 2018 batch. Computational antibody design
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already desig…
Macromoltek was part of Y Combinator's Winter 2018 batch.
Macromoltek has a team of 14 people according to Y Combinator's directory.
Macromoltek is currently listed as Active with a team of 14 in Y Combinator's directory.
Loading interactive view…